AE-1224

Our research focuses on the development of new drugs for the treatment of colon cancer, metabolic and neurodegenerative diseases.

VIEW FEATURES

AE-1224

Therapeutic area

Hypoglycemic

Target disease

Colon cancer

Study phase

Preclinical: In vitro

100%

Preclinical: In vivo

100%

Clinic I

0

Clinic II

Not initiated

Clinic III

Not initiated

Patent No.

SP-Application No. P202131112

Discover the Future

We are a biotechnology company committed to the discovery of efficient and effective bioactive principles as pharmaceuticals, nutraceuticals or useful in the field of plant biology.